Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery
Status:
Terminated
Trial end date:
2009-02-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the CollaRx Bupivacaine Implant
(bupivacaine sponge) is safe and effective in reducing the amount of narcotic pain medication
needed to control pain during the first 24 hours after gastrointestinal (GI) surgery.